ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
8.95
+0.34 (3.95%)
At close: Jul 2, 2026, 4:00 PM EDT
9.03
+0.08 (0.88%)
After-hours: Jul 2, 2026, 7:45 PM EDT
ADMA Biologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 138.15 | 87.63 | 103.15 | 51.35 | 86.52 | 51.09 |
Cash & Short-Term Investments | 138.15 | 87.63 | 103.15 | 51.35 | 86.52 | 51.09 |
Cash Growth | 92.88% | -15.04% | 100.86% | -40.65% | 69.36% | -8.64% |
Accounts Receivable | 135.86 | 158.43 | 50 | 27.42 | 15.51 | 28.58 |
Inventory | 222.1 | 206.47 | 170.24 | 172.91 | 163.28 | 124.72 |
Other Current Assets | 15.06 | 13.99 | 8.03 | 5.33 | 5.1 | 4.34 |
Total Current Assets | 511.17 | 466.51 | 331.41 | 257.01 | 270.4 | 208.73 |
Net Property, Plant & Equipment | 71.41 | 71.71 | 63.34 | 63.47 | 68.75 | 58.2 |
Other Intangible Assets | 0.63 | 0.63 | 0.46 | 0.5 | 1.01 | 1.73 |
Goodwill | 3.53 | 3.53 | 3.53 | 3.53 | 3.53 | 3.53 |
Other Long-Term Assets | 78.44 | 81.86 | 89.94 | 4.67 | 4.77 | 4.07 |
Total Assets | 665.18 | 624.24 | 488.68 | 329.18 | 348.46 | 276.25 |
Accounts Payable | 20.52 | 22.52 | 20.22 | 15.66 | 13.23 | 12.43 |
Accrued Expenses | 48.56 | 40.47 | 34.11 | 32.92 | 24.99 | 17.22 |
Current Portion of Long-Term Debt | 3.28 | 2.81 | - | - | - | - |
Current Portion of Leases | 1.18 | 1.1 | 1.22 | 1.05 | 0.91 | 0.59 |
Unearned Revenue | - | - | - | 0.18 | 0.14 | 0.14 |
Other Current Liabilities | - | 2.65 | - | - | - | - |
Total Current Liabilities | 73.54 | 69.54 | 55.54 | 49.81 | 39.27 | 30.38 |
Long-Term Debt | 193.58 | 69.33 | 73.65 | 132.28 | 144.33 | 94.87 |
Long-Term Leases | 6.37 | 6.65 | 8.56 | 9.78 | 10.7 | 7.46 |
Other Long-Term Liabilities | 1.37 | 1.41 | 1.91 | 2.11 | 2.18 | 2.37 |
Total Long-Term Liabilities | 201.32 | 77.38 | 84.12 | 144.17 | 157.22 | 104.7 |
Total Liabilities | 274.86 | 146.92 | 139.66 | 193.98 | 196.49 | 135.08 |
Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Treasury Stock | -143.17 | -32.09 | - | - | - | - |
Additional Paid-in Capital | 649.8 | 671.04 | 657.58 | 641.44 | 629.97 | 553.27 |
Retained Earnings | -116.33 | -161.65 | -308.58 | -506.26 | -478.02 | -412.11 |
Shareholders' Equity | 390.33 | 477.32 | 349.02 | 135.21 | 151.97 | 141.17 |
Total Liabilities & Equity | 665.18 | 624.24 | 488.68 | 329.18 | 348.46 | 276.25 |
Total Debt | 204.41 | 79.89 | 83.43 | 143.11 | 155.94 | 102.92 |
Net Cash (Debt) | -66.25 | 7.75 | 19.72 | -91.75 | -69.42 | -51.83 |
Net Cash Growth | - | -60.72% | - | - | - | - |
Net Cash Per Share | -0.27 | 0.03 | 0.08 | -0.41 | -0.35 | -0.37 |
Book Value | 390.33 | 477.32 | 349.02 | 135.21 | 151.97 | 141.17 |
Book Value Per Share | 1.60 | 1.95 | 1.43 | 0.60 | 0.77 | 1.01 |
Tangible Book Value | 386.17 | 473.16 | 345.03 | 131.18 | 147.43 | 135.91 |
Tangible Book Value Per Share | 1.58 | 1.93 | 1.42 | 0.59 | 0.75 | 0.97 |